To test this, purified CLL-B cells were incubated with exogenous recombinant TL1A in the presence of anti-IgM, and cell survival was measured with Annexin V/PI staining and flow cytometry. Here, ANXA5 is linked to B-cell chronic lymphocytic leukemia.